MQS Management LLC Acquires Shares of 2,302 Integer Holdings Corporation (NYSE:ITGR)

MQS Management LLC bought a new position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 2,302 shares of the medical equipment provider's stock, valued at approximately $272,000.

Other large investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Integer during the 4th quarter worth approximately $208,000. Intech Investment Management LLC raised its position in shares of Integer by 51.1% during the 4th quarter. Intech Investment Management LLC now owns 11,767 shares of the medical equipment provider's stock worth $1,559,000 after purchasing an additional 3,980 shares during the period. HighTower Advisors LLC raised its position in shares of Integer by 1.4% during the 4th quarter. HighTower Advisors LLC now owns 12,207 shares of the medical equipment provider's stock worth $1,618,000 after purchasing an additional 166 shares during the period. Cibc World Markets Corp acquired a new stake in shares of Integer during the 4th quarter worth approximately $413,000. Finally, LPL Financial LLC raised its position in shares of Integer by 26.0% during the 4th quarter. LPL Financial LLC now owns 44,508 shares of the medical equipment provider's stock worth $6,165,000 after purchasing an additional 9,196 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Price Performance

NYSE ITGR traded down $2.36 on Thursday, reaching $114.77. 554,711 shares of the stock traded hands, compared to its average volume of 389,693. The firm's fifty day simple moving average is $119.86 and its 200 day simple moving average is $124.72. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78. The company has a market cap of $4.00 billion, a price-to-earnings ratio of 54.39, a P/E/G ratio of 1.01 and a beta of 0.98. Integer Holdings Corporation has a 12 month low of $104.93 and a 12 month high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The company's revenue was up 7.3% compared to the same quarter last year. During the same period last year, the company posted $1.14 EPS. As a group, research analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Insider Transactions at Integer

In other news, Director Donald J. Spence sold 14,739 shares of the firm's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the sale, the director directly owned 18,781 shares of the company's stock, valued at $2,260,856.78. This trade represents a 43.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer directly owned 47,000 shares of the company's stock, valued at approximately $5,788,990. This represents a 87.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock valued at $44,577,115 in the last three months. 2.16% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ITGR shares. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Truist Financial set a $150.00 target price on Integer and gave the company a "buy" rating in a research report on Friday, April 25th. Raymond James Financial raised their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, April 25th. Benchmark lowered their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Finally, Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Integer has a consensus rating of "Moderate Buy" and an average target price of $146.25.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.